According to Market Scope, the Glaucoma Surgical market segment is expected to be the highest growing market segment in ophthalmology through 2026, growing at a CAGR of nearly 19%. This underlines the huge unment need that remains for continued innovation for glaucoma patients worldwide. It also represents the exciting developments in glaucoma therapies, including Iantrek’s micro-interventional technologies, that are poised to expand options for ophthalmic surgeons treating glaucoma.
